Tirzepatide (GLP1T)
For Research Use Only
Injectable
A dual-action peptide that activates both GLP-1 and GIP receptors — the two major gut hormones that govern appetite, insulin release, and fat storage. That two-pathway approach is what sets it apart from single-action compounds: activating GIP alongside GLP-1 improves insulin sensitivity through a second route and is associated with fewer digestive side effects along the way. Clinical trial data shows this dual mechanism driving meaningfully greater metabolic results than GLP-1-only agents. Commonly used for: faster weight loss and blood sugar management
Size: 30mg
$350.00
In stockCheckout opens once payment is connected.
Certificates of analysis
No certificate has been published for this product yet.
Research guides
- Tirzepatide Pharmacokinetics in Animal Models: What the Published Literature ReportsA research-framed summary of published findings on tirzepatide disposition in rats, including a validated LC-MS/MS bioanalytical method, reported terminal half-lives after intravenous and subcutaneous administration, and estimated subcutaneous bioavailability, alongside a scoping review mapping preclinical and clinical evidence for this dual GIP/GLP-1 receptor agonist.
This product is not for human or animal consumption. Misuse of this product is illegal.